(Q48931973)

16 February 2018

reason for preferred rank

title

Schizophrenia: Dopamine β-Hydroxylase Activity and Treatment Response (English)

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

9 August 2023

Schizophrenia: dopamine beta-hydroxylase activity and treatment response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124036

9 August 2023

1 reference

VanKammen DP

2

1 reference

16 February 2018

D. E. Sternberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124036

9 August 2023

D. P. VanKammen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124036

9 August 2023

P. Lerner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124036

9 August 2023

W. E. Bunney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124036

9 August 2023

language of work or name

English

0 references

publication date

1 June 1982

1 reference

16 February 2018

25 June 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6124036

full work available at URL

9 August 2023

https://syndication.highwire.org/content/doi/10.1126/science.6124036

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

9 August 2023

1 reference

16 February 2018

volume

216

1 reference

16 February 2018

issue

4553

1 reference

16 February 2018

page(s)

1423-1425

1 reference

16 February 2018

A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord

cites work

1

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Behavioral effects of l-Dopa in schizophrenic patients

9 August 2023

2

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Brain Norepinephrine and Dopamine in Schizophrenia

9 August 2023

3

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Journal of Psychiatric Research

9 August 2023

4

38

387

1979

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Methods for reliable longitudinal observation of behavior

9 August 2023

5

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

9 August 2023

6

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Molecular pathology of schizophrenia: more than one disease process?

9 August 2023

7

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

The effect of drugs on the concentration of dopamine β-hydroxylase in the cerebrospinal fluid of rabbits

9 August 2023

10

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

9 August 2023

Biological Psychiatry

11

6

115

1973

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

9 August 2023

12

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Dopamine-ß-hydroxylase activity in human cerebrospinal fluid and serum

9 August 2023

13

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Journal of Neurochemistry

9 August 2023

14

26

193

1976

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Immunofluorescence of dopamine- -hydroxylase. Application of improved methodology to the localization of the peripheral and central noradrenergic nervous system

9 August 2023

15

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

9 August 2023

Schizophrenia: A theory

17

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

9 August 2023

19

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

The dementia of dementia praecox.

9 August 2023

20

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

9 August 2023

Pharmacological Reviews

21

17

71

1965

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

NIH conference. Dopamine- -hydroxylase. Basic and clinical studies

9 August 2023

22

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Schizophrenia: elevated cerebrospinal fluid norepinephrine

9 August 2023

23

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Sprum dopamine-β-hydroxylase: Constancy of levels in normotensive adults and decreases with development of blood pressure elevation

9 August 2023

24

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol

9 August 2023

27

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients

9 August 2023

28

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

The dopamine hypothesis of schizophrenia: a review

9 August 2023

29

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Journal of Pharmacology and Experimental Therapeutics

9 August 2023

30

178

425

1971

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Dopamine-beta-hydroxylase activity in serum and cerebrospinal fluid in neuropsychiatric diseases

9 August 2023

32

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid

9 August 2023

34

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

9 August 2023

35

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Serum dopamine-?-hydroxylase (D?H) activity and affective states

9 August 2023

36

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Clinical criteria for psychiatric diagnosis and DSM-III

9 August 2023

37

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

The effect of pimozide on CSF norepinephrine in schizophrenia

9 August 2023

38

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia

9 August 2023

39

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment

9 August 2023

41

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Serum Dopamine-β-Hydroxylase: Decrease after Chemical Sympathectomy

9 August 2023

42

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Proportional Release of Norepinephrine and Dopamine-β-Hydroxylase from Sympathetic Nerves

9 August 2023

43

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Plasma dopamine- -hydroxylase activity in hypertension and various neuropsychiatric disorders

9 August 2023

44

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Dopamine-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients

9 August 2023

45

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

Dopamine β-Hydroxylase Activity in Brains of Chronic Schizophrenic Patients

9 August 2023

46

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.6124036

9 August 2023

Identifiers

1 reference

16 February 2018

ADS bibcode

1982Sci...216.1423S

0 references

1 reference

16 February 2018